GENETIC PREDICTORS OF RESPONSE TO TREATMENT WITH CRHR1 ANTAGONISTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150278438A1
SERIAL NO

14396477

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates inter alia to methods for predicting the response of patients with depressive symptoms and/or anxiety symptoms to treatment with a CRHR1 antagonist, and algorithms, kits, microarrays, probes and or/primers for use in such methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E VHOFGARTENSTRASSE 8 MÜNCHEN 80539

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Binder, Elisabeth Munchen, DE 4 6
Holsboer, Florian Munchen, DE 23 32
Müller-Myhsok, Bertram Munchen, DE 7 14

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation